NYBC Ventures

Sobre

NYBC Ventures is the $50M venture fund established by New York Blood Center Enterprises. It targets early- to mid-stage innovations in hematology, transfusion medicine, cell therapy, infectious disease, and supporting blood and cellular-therapy technologies.

Sectores

• Ciencias de la vida

Inversiones destacadas

• Akadeum
• Aronora
• Avencell
• Catena Bio
• Cell Origin
• Functional Fluidics
• Immusoft
• KaloCyte
• STRM.Bio
• Thymmune

Inversores

• Christopher D. HillyerGeneral Partner, Manager→
• Jay MohrGeneral Partner, Manager→
• Meg WoodManaging Director→
• Kuan YuSenior Analyst→